Rocket


News + Filings
Transactions





All
All (ex-4s)
10-K
10-Q
8-K
3,4,5
Proxy
Prospectus
Other


Epperly Melissa B, Create: Alert

All | News | Filings
Date FiledTypeDescription
10/06/2023 4 Epperly Melissa B, (CFO) has filed a Form 4 on Zentalis Pharmaceuticals, Inc.
Txns: Sold 4,594 shares @ $19.4265, valued at $89.2k
Sold 888 shares @ $19.9102, valued at $17.7k
07/06/2023 4 Epperly Melissa B, (Director) has filed a Form 4 on Roivant Sciences Ltd.
Txns: Granted 1,280 shares @ $0
06/16/2023 4 Epperly Melissa B, (Director) has filed a Form 4 on Nautilus Biotechnology, Inc.
Txns: Granted 45,000 options to buy @ $3.97, valued at $178.7k
02/14/2023 4 Epperly Melissa B, (CFO) has filed a Form 4 on Zentalis Pharmaceuticals, Inc.
Txns: Sold 2,624 shares @ $20.4244, valued at $53.6k
Sold 5,227 shares @ $19.9753, valued at $104.4k
02/01/2023 4 Form 4 - Statement of changes in beneficial ownership of securities:
10/03/2022 4 Epperly Melissa B, (CFO) has filed a Form 4 on Zentalis Pharmaceuticals, Inc.
Txns: Granted 50,000 shares @ $0
07/25/2022 4 Form 4 - Statement of changes in beneficial ownership of securities:
07/11/2022 3 Form 3 - Initial statement of beneficial ownership of securities:
06/16/2022 4 Form 4 - Statement of changes in beneficial ownership of securities:
06/15/2022 4 Epperly Melissa B, (Director) has filed a Form 4 on Kinnate Biopharma Inc.
Txns: Granted 20,250 options to buy @ $8.38, valued at $169.7k
04/05/2022 4 Epperly Melissa B, (CFO) has filed a Form 4 on Zentalis Pharmaceuticals, Inc.
Txns: Sold 8,094 shares @ $48.7475, valued at $394.6k
Sold 1,303 shares @ $49.9018, valued at $65k
Sold 2,818 shares @ $50.6975, valued at $142.9k
Sold 4,512 shares @ $51.9862, valued at $234.6k
Sold 353 shares @ $52.4386, valued at $18.5k
02/23/2022 4 Form 4 - Statement of changes in beneficial ownership of securities:
02/14/2022 4 Epperly Melissa B, (CFO) has filed a Form 4 on Zentalis Pharmaceuticals, Inc.
Txns: Granted 16,405 shares @ $0
Granted 38,489 options to buy @ $52.61, valued at $2M
10/04/2021 4 Epperly Melissa B, (CFO) has filed a Form 4 on Zentalis Pharmaceuticals, Inc.
Txns: Paid exercise price by delivering 17,080 shares @ $67.13, valued at $1.1M
07/06/2021 4 Epperly Melissa B, (CFO) has filed a Form 4 on Zentalis Pharmaceuticals, Inc.
Txns: Sold 700 shares @ $50.1043, valued at $35.1k
Sold 1,378 shares @ $51.1461, valued at $70.5k
Sold 805 shares @ $52.0062, valued at $41.9k
Sold 200 shares @ $53.185, valued at $10.6k
06/14/2021 4 Epperly Melissa B, (Director) has filed a Form 4 on Kinnate Biopharma Inc.
Txns: Granted 20,250 options to buy @ $24.46, valued at $495.3k
06/09/2021 3 Epperly Melissa B, (Director) has filed a Form 3 on Nautilus Biotechnology, Inc.
06/02/2021 4 Epperly Melissa B, (CFO) has filed a Form 4 on Zentalis Pharmaceuticals, Inc.
Txns: Sold 2,883 shares @ $53.9927, valued at $155.7k
Sold 200 shares @ $54.9, valued at $11k
05/05/2021 4 Epperly Melissa B, (CFO) has filed a Form 4 on Zentalis Pharmaceuticals, Inc.
Txns: Sold 350 shares @ $56.9943, valued at $19.9k
Sold 661 shares @ $58.0449, valued at $38.4k
Sold 950 shares @ $59.8307, valued at $56.8k
Sold 1,122 shares @ $60.1425, valued at $67.5k
04/06/2021 4 Epperly Melissa B, (CFO) has filed a Form 4 on Zentalis Pharmaceuticals, Inc.
Txns: Sold 3,083 shares @ $43.4303, valued at $133.9k
Sold 13,792 shares @ $43.3657, valued at $598.1k
Sold 149 shares @ $44.2148, valued at $6.6k
Sold 83 shares @ $45.0606, valued at $3.7k
03/03/2021 4 Epperly Melissa B, (CFO) has filed a Form 4 on Zentalis Pharmaceuticals, Inc.
Txns: Sold 3,083 shares @ $41.6745, valued at $128.5k
02/16/2021 4 Epperly Melissa B, (CFO) has filed a Form 4 on Zentalis Pharmaceuticals, Inc.
Txns: Granted 15,000 shares @ $0
Granted 45,000 options to buy @ $38.76, valued at $1.7M
02/03/2021 4 Epperly Melissa B, (CFO) has filed a Form 4 on Zentalis Pharmaceuticals, Inc.
Txns: Sold 2,700 shares @ $37.4528, valued at $101.1k
Sold 383 shares @ $38.3345, valued at $14.7k
01/06/2021 4 Form 4 - Statement of changes in beneficial ownership of securities:
12/08/2020 4 Epperly Melissa B, (CFO) has filed a Form 4 on Zentalis Pharmaceuticals, Inc.
Txns: Sold 3,343 shares @ $50.7627, valued at $169.7k
Sold 3,877 shares @ $51.1728, valued at $198.4k
Sold 119 shares @ $50.839, valued at $6k
Sold 971 shares @ $52.5293, valued at $51k
Sold 4,983 shares @ $53.7111, valued at $267.6k
Sold 391 shares @ $54.3863, valued at $21.3k
12/03/2020 4 Epperly Melissa B, (CFO) has filed a Form 4 on Zentalis Pharmaceuticals, Inc.
Txns: Sold 700 shares @ $50.3386, valued at $35.2k
Sold 1,525 shares @ $51.3267, valued at $78.3k
Sold 500 shares @ $52.272, valued at $26.1k
Sold 358 shares @ $53.1691, valued at $19k
12/02/2020 3 Epperly Melissa B, (Director) has filed a Form 3 on Kinnate Biopharma Inc.
11/25/2020 4 Epperly Melissa B, (CFO) has filed a Form 4 on Zentalis Pharmaceuticals, Inc.
Txns: Bought 20,000 shares @ $18, valued at $360k
Sold 2,783 shares @ $46.5097, valued at $129.4k
Sold 300 shares @ $47.2567, valued at $14.2k
04/09/2020 4 Epperly Melissa B, (CFO) has filed a Form 4 on Zentalis Pharmaceuticals, Inc.
Txns: Granted 147,394 shares @ $0
04/03/2020 3 Epperly Melissa B, (CFO) has filed a Form 3 on Zentalis Pharmaceuticals, LLC

Rocket Data Systems, Inc. © 2019 | Contact Us | Data Disclaimer | Terms of Use | Privacy